Nivolumab Versus Docetaxel for Previously Treated Advanced...

  • Main
  • 2019 / 11
  • Nivolumab Versus Docetaxel for Previously Treated Advanced...

Nivolumab Versus Docetaxel for Previously Treated Advanced Non-Small Cell Lung Cancer in China: A Cost-Effectiveness Analysis

Liu, Qiao, Luo, Xia, Peng, Liubao, Yi, Lidan, Wan, Xiaomin, Zeng, Xiaohui, Tan, Chongqing
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Drug Investigation
DOI:
10.1007/s40261-019-00869-3
Date:
November, 2019
File:
PDF, 881 KB
english, 2019
Conversion to is in progress
Conversion to is failed